Untargeted metabolomics reveals the impact of Liraglutide treatment on metabolome profiling and metabolic pathways in type-2 diabetes mellitus

Hicham Benabdelkamel; Rajaa Sebaa; Reem H. AlMalki; Afshan Masood; Assim A. Alfadda; Anas M. Abdel Rahman

doi:10.1016/j.jsps.2024.102172

10.1016/j.jsps.2024.102172 417 المشاهدات 6 الاقتباسات

الاقتباسات

417

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Hicham, B., Rajaa, S., Reem, H. A., Afshan, M., Assim, A. A., Anas, M. A. R. (2024). Untargeted metabolomics reveals the impact of Liraglutide treatment on metabolome profiling and metabolic pathways in type-2 diabetes mellitus. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102172

Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024

استشهاد

433

Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems

Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024

استشهاد

483

A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities

Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024

استشهاد

512

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …